Eclipse Toxicology, Ltd. — Form D/A
Eclipse Toxicology, Ltd. of SAN ANTONIO, TX, a company, filed a Form D amendment with the SEC on 2016-01-21. The offering totals $2.2M, of which $1.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2016-01-21
- Form: D/A
- Accession: 0001162677-16-000143
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.2M
- Amount sold: $1.3M
- Remaining: $882K
- Minimum investment: $12K
- Investors: 62
- Date of first sale: 2015-03-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-237026
Issuer
- Name: Eclipse Toxicology, Ltd.
- CIK: 0001635400
- Entity type: Limited Partnership
- Jurisdiction: TEXAS
- Incorporated: 2014
- Address: 1077 CENTRAL PARKWAY S., SAN ANTONIO, TX, 78232
- Phone: 210-765-5019
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| N/A Eclipse Lab Management, LLC | Director | San Antonio, TX |
| Lance Hupfield | Executive Officer | San Antonio, TX |
| Abdou Mekebri | Executive Officer | San Antonio, TX |
| Chris Shoup | Executive Officer | San Antonio, TX |
| Bradley West | Executive Officer | San Antonio, TX |
| William (Wade) White | Executive Officer | San Antonio, TX |
| Richey Wyatt | Executive Officer | San Antonio, TX |
Other filings by this issuer (1)
More